Trademark: 87114798
Word
AUREALIS PHARMA
Status
Registered
Status Code
700
Status Date
Tuesday, January 23, 2018
Serial Number
87114798
Registration Number
5383359
Registration Date
Tuesday, January 23, 2018
Mark Type
4000
Filing Date
Monday, July 25, 2016
Published for Opposition
Tuesday, October 17, 2017

Trademark Owner History
Aurealis Pharma AG - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human beings and animals; prokaryotic organisms, namely, genetically modified bacteria, bacteria producing growth factors, antibodies, immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines; medicines for human purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; medicines for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; bacteriological preparations for medical and veterinary use, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for pharmaceutical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, specifically autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer
"PHARMA"

Trademark Events
Jan 23, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 23, 2018
Registered-Principal Register
Dec 15, 2017
Notice Of Allowance Cancelled
Dec 12, 2017
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2017
Published For Opposition
Sep 27, 2017
Notification Of Notice Of Publication E-Mailed
Sep 11, 2017
Approved For Pub - Principal Register
Aug 16, 2017
Teas/Email Correspondence Entered
Aug 16, 2017
Correspondence Received In Law Office
Aug 10, 2017
Assigned To Lie
Jul 14, 2017
Teas Response To Suspension Inquiry Received
May 12, 2017
Notification Of Letter Of Suspension E-Mailed
May 12, 2017
Letter Of Suspension E-Mailed
May 12, 2017
Suspension Letter Written
May 11, 2017
Teas/Email Correspondence Entered
May 9, 2017
Correspondence Received In Law Office
May 9, 2017
Teas Response To Office Action Received
Nov 10, 2016
Notification Of Non-Final Action E-Mailed
Nov 10, 2016
Non-Final Action E-Mailed
Nov 10, 2016
Non-Final Action Written
Nov 3, 2016
Assigned To Examiner
Jul 28, 2016
New Application Office Supplied Data Entered
Jul 28, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24